Earnings Call · Q3 FY2024·2024-11-05

Q3 24EPS +8.33%·Rev n/aQ2 24EPS +90.91%·Rev n/aQ1 24EPS -100.00%*·Rev n/aQ4 23EPS -28.57%·Rev n/a⚠ consensus missing

Aquestive Therapeutics, Inc. AQST

Bennett Watson — Unknown (likely Investor Relations or Corporate Communications)

Dan Barber — Chief Executive Officer

Ernie Toth — Chief Financial Officer

−7.7%1d on move date−8.9% vs SPY3d−1.4%5d−1.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AQST calls or request research access.

More AQST calls Browse calls Request research access